Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 2 January 2027
- Last conf. stmt
- 19 December 2025
Ventus Medical Limited
- Incorporated
- 22 December 2014 (11 years)
- Previously known as
- Project Paradise Limited (until 7 August 2019)This list may be incomplete. See all names on Companies House
- Industry
- Other research and experimental development on natural sciences and engineering (72190)
- Owned by
- Accounts type
- Small
- Region
- North West
- Address
- 29 Speke Hall Industrial EstateLiverpoolL24 1YA
Charges
- Total
- 2
- Outstanding
- 1
- Part satisfied
- 0
- Satisfied
- 1
Officers 4 active
Officer details are public data from the Companies House register.
Irish,British
Born October 1987 (39)
Director · Appointed 13 May 2022
Also at Advent Life Sciences LLP · more companies
British
Born July 1960 (66)
Director · Appointed 18 May 2018
British
Born April 1974 (52)
Director · Appointed 3 July 2015
British
Born May 1976 (50)
Officer history (5 former)
27 March 2023
1 January 2023
Resigned Lacour-Gayet, Julien as Director
13 May 2022
13 May 2022
Resigned Lane, Laura Alexandra, Dr as Director
19 December 2019
Appointed Lacour-Gayet, Julien as Director
8 July 2019
8 July 2019
Appointed Lane, Laura Alexandra, Dr as Director
13 February 2019
18 May 2018
18 May 2018
3 July 2015
3 July 2015
22 December 2014
22 December 2014
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 6 April 2016
Owns 75–100% of shares
Holds 75–100% of voting rights
Limited Liability Partnership
Reg. no. Oc347034
Former controllers (1)
6 April 2016
Ceased Advent Life Sciences Fund II LP — Owns 50–75% of shares
Group structure 17 companies
Ownership group derived from the Companies House PSC register
Advent Life Sciences GP LLP Right to 75–100% of surplus assets
Advent LS Services Limited Owns 75–100% of shares
Als Growth GP LLP Right to 75–100% of surplus assets
Als Iii Carry and Co-Invest GP LLP Holds 25–50% of voting rights
Als Carry LP Has significant influence or control
Als Iii Carry and Co-Invest LP Part right to 50–75% of surplus assets (as a firm)
Als Iii GP LLP Holds 75–100% of voting rights
Als Iii Member Co Limited Owns 75–100% of shares
Als IV Carry and Co-Invest LP Part right to 75–100% of surplus assets
Als IV Carry and Co-Invest GP LLP Holds 25–50% of voting rights
Alsgf Carry and Co-Invest GP LLP Holds 25–50% of voting rights
Alsgf Carry and Co-Invest LP Has significant influence or control
Cenentry Biosciences Limited Owns 25–50% of shares
Fiera Oncology Limited Owns 25–50% of shares
Pheno Therapeutics Limited Owns 50–75% of shares (as a firm)
Ventus Medical Limited This company Owns 75–100% of shares
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 15 September 2026 | Resolutions | |||
| 9 September 2026 | Accounts for a small company | 31 December 2025 |
Some other companies at this address
Other companies in this industry
Stevenage
Reading
Didcot
London
Sandwich
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →